A total of nine companies have been accepted into Bayer’s Digital Health Partnership Program, as annouced on the EU Startups website recently.
In 2021, the pharmaceutical company was specifically looking for young companies with expertise in the focus areas of mental health, cardiometabolic and reneal diseases, radiology and women’s health across Europe.
WHAT’S THE IMPACT
The finalists were...
Pharma giant Novartis is looking for creative, digital solutions that sustainably improve German healthcare.
The company has annouced the fifth installment of the Digital Health Award, with prize money of €60,000 in total available for winners.
The awards presentation takes place in Berlin on 24 March 2022, while the call is open for applications until 30 November 2021.
WHAT’S THE IMPACT
With the...
DeepCure, developer of small molecule therapeutics using an AI-enabled drug discovery platform, raised $40 million in Series A funding.
The round was led by Morningside Ventures with participation from existing investors TLV Partners, Sapir Venture Partners and Benon Group Ltd.
DeepCure said the Series A brings its total raise to $47 million.
WHAT IT DOES
The company uses its AI engine to develop...
Health tech company Prescryptive Health has launched MyRx.io, a mobile platform that allows users to access pharmacy services like finding prescription benefit information, drug shopping and making appointments for vaccines or other pharmacy-provided care.
MyRx.io doesn’t require customers to download an app, but they can receive notifications about their prescriptions via text message. The...
The Digital Medicine Society (DiMe) is teaming up with pharma giants AbbVie, Janssen Research and Development, Novartis, Pfizer and UCB to make nocturnal scratch an endpoint for atopic dermatitis.
Atopic dermatitis, also known as eczema, can lead to nighttime itches and scratching, which impact the quality of a patient's sleep. Recent studies have outlined wearable sensors’ role in helping to...
Viome Life Sciences, maker of at-home tests for gut and immune system health, is expanding its partnership with global pharma company GlaxoSmithKline to research and potentially develop interventions for some cancers and autoimmune diseases.
The collaboration will allow the companies to study the connection between the gut microbiome and some chronic diseases, like autoimmune disorders. Viome...
Today consumers are used to getting just about everything delivered at their doorstep. But historically, getting medication required a trip to the doctor’s office and then a stop at the pharmacy. However, digital may interrupt this paradigm.
It’s no secret that medication adherence is a major issue in healthcare. While medication costs have often been pointed to as the main barrier to adherence...
PathAI, maker of AI-enabled pathology products, announced Friday it was partnering with pharma and diagnostics giant Roche.
The strategic partnership will allow PathAI to develop and distribute its AI pathology tech through Roche’s uPath enterprise software, a workflow platform for labs.
The collaboration will begin with distributing PathAI’s research-use-only algorithms through the cloud...
AstraZeneca and the Royal Academy of Engineering today (6 Oct) announced a partnership to help drive the development of health tech solutions in Africa.
The joint venture aims to establish connections between African healthcare innovators and AstraZeneca’s A.Catalyst Network, the pharma giant’s new platform with more than 20 global health innovation hubs.
In 2014 the Royal Academy of Engineering...
_1.jpg?itok=il4oytMR "Digital care applications are among the most wanted innovations in the Germany.")
_1.JPG?itok=ODXIfeEK)
